Tag: v anantha nageswaran

Biocon shares are expected to be in focus on Tuesday after the company announced regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for its diabetes drug Liraglutide in India.The Central Drugs Standard Control...
Top stocks to buy today (AI image) Stock market recommendations: According to Somil Mehta, Head - Alternate Research, Capital Market Strategy, Mirae Asset Sharekhan, Hudco and Indian Hotels are the top stocks to buy...

World Bank unveils reforms to enhance transparency

Our BureauNew Delhi: The World Bank has announced six reforms to address concerns about the Worldwide Governance Indicators (WGI) based on recommendations of...

‘Wait & watch’: India gearing up for any change in US policy, says CEA V Anantha Nageswaran

New Delhi: India is “better prepared” this time around for Donald Trump’s return to the White House, chief economic adviser (CEA) V Anantha...

Recent articles

spot_img